Moleculin Biotech, Inc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2021-06-07

Reporting Person: George Robert E. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-07	Stock option (right to buy)	$3.95	A	10000	Acquired	2031-06-07	Common Stock (10000)	Direct

Footnotes

F1: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

F2: The options were issued in connection with the reporting person's Board of Director service to the Company.